Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-13-000840
Filing Date
2013-02-14
Accepted
2013-02-14 11:10:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 c72672_sc13ga.htm SC 13G/A 95028
  Complete submission text file 0000930413-13-000840.txt   96463
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45969 | Film No.: 13607904
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2 PICKWICK PLAZA STE 450 GREENWICH CT 06830
Business Address
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A